NCT01687491View on ClinicalTrials.gov

Comparison of Anti-Xa Activity of ENOXA ® Versus LOVENOX ® in Acute Coronary Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

179

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

October 31, 2014

Conditions
Acute Coronary SyndromeFactor X
Interventions
DRUG

ENOXA®

enoxaparine 100 UI/Kg subcutaneous injection

DRUG

LOVENOX®

enoxaparine 100 UI/Kg subcutaneous injection

Trial Locations (1)

5000

Departement of Emergency, Monastir

All Listed Sponsors
collaborator

University Hospital Fattouma Bourguiba

OTHER

lead

Les Laboratoires des Médicaments Stériles

INDUSTRY

NCT01687491 - Comparison of Anti-Xa Activity of ENOXA ® Versus LOVENOX ® in Acute Coronary Syndrome | Biotech Hunter | Biotech Hunter